View in EDS HTML Full Text PDF Full Text

Targeted inhibition of the CREB1-CtIP axis enhances the efficacy of abiraterone combined with radiotherapy in prostate cancer.

Saved in:
Bibliographic Details
Title: Targeted inhibition of the CREB1-CtIP axis enhances the efficacy of abiraterone combined with radiotherapy in prostate cancer.
Authors: Han X; Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Song L; Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Feng Y; Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China., Wang Z; Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Wang L; Department of General Medicine, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, China., Liu R; Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Liu Y; Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Li N; Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Ma S; Nanozyme Medical Center, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China., Lu F; Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Yang J; Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. yangjinjian2011@126.com., Huang Z; Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. huangzl@zzu.edu.cn., Jia Z; Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. jiazhankui@126.com.
Source: Cell death & disease [Cell Death Dis] 2026 Mar 30; Vol. 17 (1). Date of Electronic Publication: 2026 Mar 30.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41912484
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Targeted inhibition of the CREB1-CtIP axis enhances the efficacy of abiraterone combined with radiotherapy in prostate cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Han+X%22">Han X</searchLink>; Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Song+L%22">Song L</searchLink>; Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Feng+Y%22">Feng Y</searchLink>; Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Wang+Z%22">Wang Z</searchLink>; Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Wang+L%22">Wang L</searchLink>; Department of General Medicine, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Liu+R%22">Liu R</searchLink>; Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Liu+Y%22">Liu Y</searchLink>; Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Li+N%22">Li N</searchLink>; Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Ma+S%22">Ma S</searchLink>; Nanozyme Medical Center, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Lu+F%22">Lu F</searchLink>; Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Yang+J%22">Yang J</searchLink>; Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. yangjinjian2011@126.com.<br /><searchLink fieldCode="AU" term="%22Huang+Z%22">Huang Z</searchLink>; Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. huangzl@zzu.edu.cn.<br /><searchLink fieldCode="AU" term="%22Jia+Z%22">Jia Z</searchLink>; Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. jiazhankui@126.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101524092%22">Cell death & disease</searchLink> [Cell Death Dis] 2026 Mar 30; Vol. 17 (1). <i>Date of Electronic Publication: </i>2026 Mar 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101524092 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-4889 (Electronic) <i>NLM ISO Abbreviation: </i>Cell Death Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41912484
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41419-026-08633-0
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Targeted inhibition of the CREB1-CtIP axis enhances the efficacy of abiraterone combined with radiotherapy in prostate cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Han X
      – PersonEntity:
          Name:
            NameFull: Song L
      – PersonEntity:
          Name:
            NameFull: Feng Y
      – PersonEntity:
          Name:
            NameFull: Wang Z
      – PersonEntity:
          Name:
            NameFull: Wang L
      – PersonEntity:
          Name:
            NameFull: Liu R
      – PersonEntity:
          Name:
            NameFull: Liu Y
      – PersonEntity:
          Name:
            NameFull: Li N
      – PersonEntity:
          Name:
            NameFull: Ma S
      – PersonEntity:
          Name:
            NameFull: Lu F
      – PersonEntity:
          Name:
            NameFull: Yang J
      – PersonEntity:
          Name:
            NameFull: Huang Z
      – PersonEntity:
          Name:
            NameFull: Jia Z
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 03
              Text: 2026 Mar 30
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2041-4889
          Numbering:
            – Type: volume
              Value: 17
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Cell death & disease
              Type: main
ResultId 1